Intomics Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 33
Employees
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 3

Intomics General Information

Description

Operator of a contract research company created to derive core biological insights from the analysis and integration of biomedical big data. The company's platform conducts biological data analysis and interpretation with applications across the drug discovery and development pipeline for pharma and biotech companies and lets users search, analyze, visualize and understand biological networks and associations, enabling a higher success rate of drug discovery and development projects for clients in the pharmaceutical industry.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Business/Productivity Software
Media and Information Services (B2B)
Decision/Risk Analysis
Primary Office
  • Lottenborgvej 26
  • Lyngby
  • 2800 Copenhagen
  • Denmark
+45 88 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Intomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2011 Completed Generating Revenue
1. Early Stage VC 10-Jul-2009 Completed Generating Revenue
To view Intomics’s complete valuation and funding history, request access »

Intomics Executive Team (6)

Name Title Board Seat Contact Info
Thomas Jensen Ph.D Co-Founder & Chief Executive Officer
Rasmus Wernersson Co-Founder & Chief Scientific Officer
Lars Jensen Ph.D Co-Founder & Member of the Scientific Advisory Board
Niclas Hansen Ph.D Co-Founder & Scientific Advisor
You’re viewing 4 of 6 executive team members. Get the full list »

Intomics Board Members (4)

Name Representing Role Since
Finn Andersen Seed Capital (Denmark) Board Member 000 0000
Jens Hansen Self Chairman 000 0000
Soren Brunak Ph.D Self Board Member & Scientific Advisor 000 0000
You’re viewing 3 of 4 board members. Get the full list »

Intomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Intomics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Accelerace Accelerator/Incubator Minority 000 0000 000000 0
Innovationsfonden Venture Capital Minority 000 0000 000000 0
PreSeed Ventures Venture Capital Minority 000 0000 000000 0
To view Intomics’s complete investors history, request access »